Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Sirolimus

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06139172Not ApplicableActive Not Recruiting

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

NCT00971789Phase 2Completed

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

Showing all 2 trials

Research Network

Common Treatments

  • Sirolimus1
  • Functional Behavioral Training Fbt1
  • Clinical Videography1
  • Fludeoxyglucose F 181
  • Positive Parenting Strategiestreatment As Usual1

Active Sponsors

  • National Cancer Institute (NCI)1
  • Rush University Medical Center1
  • Emory University1

Top Investigators

Related Conditions

  • Angelman Syndrome1
  • Fragile X Syndrome1
  • Chromosome 15q Partial Deletion1
  • Tuberous Sclerosis1
  • Creatine Deficiency Xlinked1

Activity Timeline